[General practitioner density is not associated with survival in patients with hepatocellular carcinoma]

Sante Publique (Vandoeuvre-Les-Nancy, France)
|February 16, 2019
PubMed

Insights

General practitioner (GP) density did not impact hepatocellular carcinoma (HCC) patient survival or diagnosis stage in a French region. This study found no significant difference in outcomes based on proximity to healthcare providers for HCC patients.

Area of Science:

  • Oncology
  • Public Health
  • Health Services Research

Background:

  • Hepatocellular carcinoma (HCC) is a significant global health concern.
  • Access to primary care, indicated by general practitioner (GP) density, may influence cancer patient outcomes.
  • Understanding geographic healthcare disparities is crucial for improving cancer care delivery.

Purpose of the Study:

  • To investigate the association between general practitioner (GP) density and overall survival in hepatocellular carcinoma (HCC) patients.
  • To determine if GP density affects the stage of HCC at initial diagnosis.
  • To analyze the impact of primary care accessibility on HCC patient outcomes in a specific French region.

Main Methods:

  • Retrospective analysis of 246 consecutive HCC patients from 2012-2016.
  • Data collected included clinico-biological, radiological, GP density in residence area, and HCC stage.
  • Survival analysis performed using Kaplan-Meier method and log-rank test.

Main Results:

  • No statistically significant difference in overall survival between patients in low GP density areas (median 11.7 months) and high GP density areas (median 14.8 months).
  • Tumor stage at initial diagnosis and time to multidisciplinary meeting presentation were similar across different GP density levels.
  • 20.7% of patients resided in low GP density areas (2.2-6.8 GPs/10000 inhabitants).

Conclusions:

  • General practitioner density in a patient's residential area does not significantly influence overall survival for hepatocellular carcinoma (HCC) patients.
  • GP density did not correlate with the stage of HCC at the time of initial diagnosis in this cohort.
  • Healthcare accessibility, as measured by GP density, may not be a determining factor for HCC outcomes in this specific North-Eastern French region.
Abstract

Related Concept Videos

Survival Curves01:18

Survival Curves

Survival curves are graphical representations that depict the survival experience of a population over time, offering an intuitive way to track the proportion of individuals who remain event-free at each time point. These curves are widely used in fields such as medicine, public health, and reliability engineering to visualize and compare survival probabilities across different groups or conditions.
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
698
Survival Tree01:19

Survival Tree

Survival trees are a non-parametric method used in survival analysis to model the relationship between a set of covariates and the time until an event of interest occurs, often referred to as the "time-to-event" or "survival time." This method is particularly useful when dealing with censored data, where the event has not occurred for some individuals by the end of the study period, or when the exact time of the event is unknown.
 Building a Survival Tree
Constructing a...
418
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
771
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
583
Truncation in Survival Analysis01:09

Truncation in Survival Analysis

Truncation in survival analysis refers to the exclusion of individuals or events from the dataset based on specific criteria related to the time of the event. This exclusion can happen in two primary forms: left truncation and right truncation.
Left truncation occurs when individuals who experienced the event of interest before a certain time are not included in the study. This is often due to a "delayed entry" into the study where only those who survive until a certain entry point are...
612
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
416